Understanding Musculoskeletal Health and Management Tips with Marfan and Loeys-Dietz Syndromes.
Dr Hanadi Kazkaz -Consultant University College London HospitalUCH Hypermobility service clinical leadChief medical advisor EDS UKMedical Advisor Marfan Trust
How to Distinguish Marfan Syndrome from Marfanoid Habitus in a Physical Examination—Comparison of External Features in Patients with Marfan Syndrome and Marfanoid Habitus
Marfan Syndrome (MFS) is a systemic disorder caused by mutations in fibrillin-1. The most common cause of mortality in MFS is dissection and rupture of the aorta. Due to a highly variable and age-dependent clinical spectrum, the diagnosis of MFS ...
PPT - Marfan Syndrome Also known as Arachnodactyly, MFS, & Marfan Syndrome Type 1 and Type 2 PowerPoint Presentation - ID:5323721
Marfan Syndrome Also known as Arachnodactyly, MFS, & Marfan Syndrome Type 1 and Type 2. By: Kianna Thompson. What is Marfan Syndrome?. It’s an inherited disorder of connective tissue, the tissue that supports your heart valves, cartilage, and vessel walls. Slideshow 5323721 by gavan
Marfan Syndrome and. Aortic Dissection. Briefly: What is it? A single gene mutation causing defective production of fibrillin in the extracellular matrices of body systems. Uh Huh? So what does that mean?. Slideshow 2938953 by ciro
...vitamin B12 deficiency secondary to atrophic gastritis caused by H. pylori. After successful treatment of H. pylori and initiation of both intramuscular injection and oral administration of vitamin B12, glossitis and anaemia improved within 1 month
Megaloblastic anemia (MA) encompasses a heterogeneous group of macrocytic anemias characterized by the presence of large red blood cell precursors called megaloblasts in the bone marrow.[1] This condition is due to impaired DNA synthesis, which inhibits nuclear division. Cytoplasmic maturation, mainly dependent on RNA and protein synthesis, is less impaired. This leads to an asynchronous maturation between the nucleus and cytoplasm of erythroblasts, explaining the large size of the megaloblasts.[2] The process affects hematopoiesis as well as rapidly renewing tissues such as gastrointestinal cells. Megaloblastic anemia is most often due to hypovitaminosis, specifically vitamin B12 (cobalamin) and folate deficiencies, which are necessary for the synthesis of DNA.[3] Copper deficiency and adverse drug reactions (due to drug interference with DNA synthesis) are other well-known causes of megaloblastic anemia. A rare hereditary disorder known as thiamine-responsive megaloblastic anemia syndrome (TRMA) is also identified as a cause of megaloblastic anemia.[4] The list of drugs associated with the disease is long however, frequently implicated agents include hydroxyurea, chemotherapeutic agents, anticonvulsants, and antiretroviral therapy (ART) drugs.
Evidence for increased catabolism of vitamin B-6 during systemic inflammation - PubMed
Broad-specificity enzymes upregulated to reduce oxidative and aldehyde stress could explain increased catabolism of vitamin B-6 during inflammation. The ratio PA:(PL + PLP) may provide novel insights into pathologic processes and potentially predict risk of future disease.
Sarcopenia is the gradual loss of muscle mass, strength and function. The condition commonly affects the elderly population and is thought to occur due to aging.
Sarcopenia (ICD-10-CM code M62.84[1]) is a type of muscle loss that occurs with aging and/or immobility. It is characterized by the degenerative loss of skeletal muscle mass, quality, and strength.
Cachexia (/kəˈkɛksiə/ ⓘ[1]) is a syndrome that happens when people have certain illnesses, causing muscle loss that cannot be fully reversed with improved nutrition.
Anal fissure: Symptoms, causes and prevention | Bupa UK
An anal fissure is a small tear in your back passage that can cause pain when you poo. Learn about the causes, symptoms, and treatments for anal fissure.
Specialist dietician Elizabeth MacCann explains what IBD is, its symptoms and what treatments are available, and how it’s different to conditions such as IBS.
Hepatic encephalopathy is characterized by a range of neuropsychiatric abnormalities caused by the accumulation of neurotoxic substances in the bloodstream of patients with liver dysfunction. It is considered a diagnosis of exclusion. The condition differs in patients with chronic liver disease compared to those with acute liver failure or acute-on-chronic liver failure (ACLF), with distinctions in pathophysiological, clinical, and radiological features.[1] Symptoms may result from liver insufficiency or the diversion of blood flow away from the liver (portosystemic shunting).